Docket Room.
HB 400·MD·house

Biotechnology Investment Incentive Tax Credit - Conversion to Grant Program

FailedFiled Jan 22, 2026
Sponsor: Chang
Latest Action

Hearing (House)

Feb 12, 2026

Summary

The bill replaces the Biotechnology Investment Incentive Tax Credit with a grant program and creates a dedicated fund. It sets eligibility rules, grant amounts, timelines for investment proof, and recapture penalties, and obligates the governor to appropriate $10 million each year. The change is intended to give biotech companies and their investors direct cash support while keeping oversight in the Department of Commerce.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about HB 400

3 free questions a day, no account

Hearings

History

  1. Hearing 2/12 at 1:00 p.m.
  2. First Reading Ways and Means

Sponsors

  • Chang · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when HB 400 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track HB 400 free

Or ask your AI assistant about HB 400 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice